GLP-1 treatment benefits patients on statins and with varying LDL levels.
Read More »Effects of Intensive Control on Quality of Life in Type 2 Diabetes
Will perceived quality of life be affected by increasing antidiabetes medication burden on the patient?
Read More »Diuretics and Risk of Lower Limb Amputation in People Who Have Type 2 Diabetes
New study shows diuresis, canagliflozin use nearly doubled risk of complications.
Read More »Preserving Beta-cell Function in Youth Newly Diagnosed with Type 2 or Prediabetes
The beta-cell preserving properties of short courses of metformin and insulin glargine evaluated in ever-growing population of patients who have diabetes.
Read More »Ethnicity Plays A Role In Diabetes Drug Selection
The best medication therapy for an individual with type 2 diabetes can depend on many factors, including ethnicity and multiple drug options.
Read More »Coffee Consumption and Diabetes: The Final Word?
Conflicting data exists about the association between coffee consumption and its effects on blood glucose, insulin concentration, and risk of type 2 diabetes.
Read More »Possible Breakthrough In Treating Type 2 Diabetes and Prediabetes
Free potential treatment lowers blood sugars, helps with weight loss, drops blood pressure and cholesterol, and may add at least 10 years of quality of life.
Read More »Oral Semaglutide Shows Promise in HbA1c Reduction and Weight Loss
First oral GLP-1 agonist undergoing Phase 3 trials shows significant benefits managing type 2 diabetes.
Read More »Albiglutide’s Effect on Cardiovascular Outcomes in People with Type 2 Diabetes
Study looks at convenient once-weekly GLP-1 that can reduce chances of heart attacks and strokes.
Read More »Biomarkers to Predict Cardiovascular Events in People with Type 2 Diabetes
The SUMMIT VIP study shows conventional risk factors do not suffice in predicting heart complications.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.